Not sure about legality. I asked a simple question
Post# of 15624
When is the trial in the US to begin. And can the results of the trial in Israel be submitted to the FDA for consideration or approval?
Pretty straight forward and nothing that could be considered insider info. This is the type info that needs to be disseminated to the public. Actually, if the trials in Israel can be submitted to the FDA for approval, that's a material event. If not, then that also is a material event.
They want to be up to date with their research using 8K's , IMHO all material events should be disseminated the same way.
Remember, from the time of a material to filing con only be 4 days to be SEC compliant.